Simon Feys

Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European Confederation of Medical Mycology

Juergen Prattes, Joost Wauters, Daniele Roberto Giacobbe et al. · Clinical Microbiology and Infection · 2021 · 219 citations · Full text

Multinational Observational Cohort Study of COVID-19–Associated Pulmonary Aspergillosis1

Nico Janssen, Rémy Nyga, Lore Vanderbeke et al. · Emerging infectious diseases · 2021 · 136 citations · Full text

Covid-19–associated Pulmonary Aspergillosis1, Clinical Epidemiology, Several Factors +9

Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study

Simon Feys, Samuel M. Gonçalves, Mona Khan et al. · The Lancet Respiratory Medicine · 2022 · 106 citations · Full text

Lung Inflammation, Respiratory Diseases, Covid-19-associated Pulmonary Aspergillosis +10

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Lore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al. · Intensive Care Medicine · 2021 · 91 citations · Full text

Proof-of-concept Trial, Antifungal Agent, Ill Influenza Patients +7

The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution

Laura de Rooij, Lisa M. Becker, Laure-Anne Teuwen et al. · Cardiovascular Research · 2022 · 59 citations · Full text

Acute Lung Injury, Inflammatory Lung Disease, Advanced Lung Disease +22